Conning »

Biomarin Pharmaceutical shares owned by Conning

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Conning from 13F filings

Historical chart of Conning investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Conning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Conning

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6M 2.7M 0.95

More positions owned by Conning

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
JPMorgan Chase & Co. (JPM)
Caterpillar (CAT)
Abbvie (ABBV)
Corning Incorporated (GLW)
Raytheon Technologies Corp (RTX)
Ishares Tr Mbs Etf (MBB)
Union Pacific Corporation (UNP)
Exxon Mobil Corporation (XOM)
Lockheed Martin Corporation (LMT)
Cummins (CMI)
Blackrock (BLK)
Qualcomm (QCOM)

View all positions for Conning

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical